Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis.
Previous cytogenetic and loss of heterozygosity (LOH) data suggest that disruption of chromosome 11q23-qter occurs frequently in epithelial ovarian cancer and is associated with an adverse clinicopathological phenotype. Ten polymorphic microsatellite repeat loci were analyzed by PCR from the 11q22-q25 region between D11S35 and D11S968 in 40 ovarian tumors (including 31 epithelial ovarian cancers). Two distinct regions of loss were detected, suggesting possible sites for genes involved in epithelial ovarian neoplasia: a large centromeric region between D11S35 and D11S933 (11q22-q23.3) and a telomeric 8.5-Mb region lying between D11S934 and D11S1320 (11q23.3-24.3) not previously defined. LOH of the latter region but not the former one was significantly associated with poor survival, despite all tumors in this study having LOH somewhere on chromosome 11. This analysis provides a starting point for positional cloning.
Gabra
H
H
Imperial Cancer Research Fund, Western General Hospital, Edinburgh, United Kingdom.
Watson
J E
JE
Taylor
K J
KJ
Mackay
J
J
Leonard
R C
RC
Steel
C M
CM
Porteous
D J
DJ
Smyth
J F
JF
D002277:Carcinoma / Q000235:genetics* / Q000503:physiopathology; D002874:Chromosome Mapping; D002880:Chromosomes, Human, Pair 11; D005260:Female; D006579:Heterozygote; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000503:physiopathology; D016019:Survival Analysis